Organization | DeNova Research

DeNova Research Report issue

For profit Phase 1 Phase 2 Phase 3 Phase 4

Founded: Chicago IL United States (2007)

Organization Overview

First Clinical Trial

2008

NCT00765375

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2022

Timeline

NOW

Now

Alternative names

DeNova Research | DeNova Research/ Chicago Center for Facial Plastic Surgery

Active Ingredients

Drugs in Phase 4 Trials (3)

arnica (1 trial)

collagenase clostridium histolyticum (xiaflex) (1 trial)

hydroxyapatite silica (1 trial)

Drugs in Phase 3 Trials (1)

hyaluronic acid (3 trials)

Drugs in Phase 2 Trials (4)

human fibrin (Tisseel) (1 trial)

incobotulinumtoxinA (Xeomin) (1 trial)

rimabotulinumtoxinB (Myobloc) (2 trials)

sodium chloride (3 trials)

Drugs in Phase 1 Trials (1)

onabotulinumtoxinA (Botox) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Acne Vulgaris (Phase 2)

Congenital Abnormalities (Phase 1)

Rosacea (Phase 2)

Overview

Highest Phase: Phase 4
# of Trials: 10
# of Trial APIs: 9